Christopher Ames, MD, director of spinal tumor and spinal deformity surgery at UC San Francisco Medical Center, was assisted by Patrick Maloney, MD, in the procedure.
Aprevo is the only spine technology to receive the FDA’s breakthrough device designation, according to the company.
The aprevo portfolio is designed to “eliminate the tedious and costly process of stock device inventory control and reprocessing,” Carlsmed CEO Mike Cordonnier said in a Feb. 23 news release.
More articles on spine:
Will disc replacement supersede spinal fusion? 7 spine surgeons weigh in
FDA clears two surgical robots focused on imaging, spine
These CMS changes would significantly improve spine care: 6 surgeons weigh in
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
